Dr. Noynika Shukla. AI-Driven Precision Targeting Beyond KRAS: Daraxonrasib, Pan-RAS(ON) Inhibition, and Emerging Predictive Biomarkers in RAS-Driven Cancers . IJESH [Internet]. 2025 Jun. 26 [cited 2026 Sep. 13];15(2):500-12. Available from: https://www.ijesh.com/j/article/view/1152